The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients-Reference-Cited by-同舟云学术

The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients

Author:

Cai Dongjing¹²^ORCID,Hu Chengping¹²^ORCID,Li Li¹²^ORCID,Deng Shichao¹²^ORCID,Yang Jing¹²^ORCID,Han‐Zhang Han³,Li Min¹²⁴⁵^ORCID

Affiliation:

1. Department of Respiratory Medicine Xiangya Hospital Central South University Changsha Hunan China

2. National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha Hunan China

3. Burning Rock Biotech Guangzhou International Biotech Island Guangzhou China

4. Center for Molecular Medicine Xiangya Hospital Central South University Changsha Hunan China

5. Key Laboratory of Molecular Radiation Oncology of Hunan Province Changsha Hunan China

Funder

National Key R&D Program of China

Central South University

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

Reference25 articles.

5. The in cis compound EGFR mutations in Chinese advanced non‐small cell lung cancer patients;Li M;Cancer Biol Ther,2019

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献